CG Oncology (CGON) Ownership - Who owns CG Oncology?
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CGON showed earnings on March 28, 2025. You can read more about the earnings report here.